Clinical trial
Starling Continuous Renal Replacement Therapy (CRRT) Observational Study
NCT05729048 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Starling Continuous Renal Replacement Therapy (CRRT) Observational Study
- Lead sponsor
- Baxter Healthcare Corporation
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- July 15, 2023
- Completion date
- March 14, 2025
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodynamic monitoring